// App-Quantinova.ai

: Impact of baseline clinical asthma characteristics on the response to mepolizumab: a post hoc meta-analysis of two Phase III trials

Researchers

Presenter

  • Mark Liu

Principal Investigators

  • Camille Taill

  • Jason Lee

  • Steven Smith

  • Steve Mallett

  • Neil Martin

  • Peter Howarth

  • Steven Yancey

  • Catherine Lemiere

Medical Centers

  • Pulmonary and Critical Care Medicine, Johns Hopkins Asthma and Allergy Center, Baltimore, MD, USA

  • Hôpital Bichat, AP-HP-Nord, Université de Paris, F-CRIN CRISALIS, Paris, France

  • Toronto Allergy and Asthma Clinic, Toronto, ON, Canada

  • GSK, Research Triangle Park, NC, USA

  • GSK, Stockley Park, Uxbridge, Middlesex, UK

  • GSK, Brentford, Middlesex, UK

  • Université de Montréal, Montreal, QC Canada, Hôpital du Sacré-Cœur de Montréal, Montreal, QC Canada

Locations

  • United States

  • France

  • Canada

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • Recepteur d'Origine Nantais

Drug/Treatment

  • Mepolizumab

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved